← Leaderboards
Nader Rahimi
Boston University Medical Campus
$4,084,287
Attributed
$4,084,287
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $427.3K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,084,287 · 7
By mechanism
R01$2,808,168 · 2
R21$783,306 · 2
R03$485,125 · 1
P41$7,688 · 2
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Peter B. O'Connor$1,925,215
- Catherine E. Costello$27,592,140
- Chi-Wei Lin$405,505
- Kevin Brown Chandler$168,006
- Leila Birolo$10,760
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisVascular Endothelial Growth FactorsPhosphorylationBaseAntiangiogenesis TherapyAdverse EffectsCellsMolecularMalignant NeoplasmsReceptorBiological Signal TransductionVascular Endothelial Growth Factor Receptor-2SiteIn VitroInvestigationIn VivoTumor GrowthProteinsLigandsMediatingAngiogenesis InhibitorsEndothelial CellsSignal TransductionColorectal Cancer
Grant awards (17)
IGPR-1 in colon cancer chemotherapy$178,024
R21 · FY2016 · CA · contact PI
Overcoming the resistance to anti-angiogenesis therapy$178,024
R21 · FY2016 · CA · contact PI
IGPR-1 in colon cancer chemotherapy$213,629
R21 · FY2015 · CA · contact PI
Overcoming the resistance to anti-angiogenesis therapy$213,629
R21 · FY2015 · CA · contact PI
IDENTIFICATION OF PHOSPHORYLATION SITES ON TUMOR CELL INVASION PROTEIN$4,616
P41 · FY2011 · RR · contact PI
POTENTIAL ROLE OF BETA-TRCP1 UBIQUITIN E3 LIGASE IN ANGIOGENESIS$3,072
P41 · FY2011 · RR · contact PI
Role of Protein Ubiquitination in Angiogenesis$402,188
R01 · FY2010 · EY · contact PI
Role of Protein Ubiquitination in Angiogenesis$406,250
R01 · FY2009 · EY · contact PI
Role of Protein Ubiquitination in Angiogenesis$406,250
R01 · FY2008 · EY · contact PI
VEGFR-1 and VEGFR-2 in angiogenesis$315,410
R01 · FY2006 · EY · contact PI
VEGFR-1 and VEGFR-2 in angiogenesis$323,000
R01 · FY2005 · EY
VEGFR-1 and VEGFR-2 in angiogenesis$317,764
R01 · FY2004 · EY
Anti-angiogenic signaling molecules in retinal cells$161,500
R03 · FY2004 · EY
VEGFR-1 and VEGFR-2 in angiogenesis$319,679
R01 · FY2003 · EY
Anti-angiogenic signaling molecules in retinal cells$161,500
R03 · FY2003 · EY
VEGFR-1 and VEGFR-2 in angiogenesis$317,627
R01 · FY2002 · EY
Anti-angiogenic signaling molecules in retinal cells$162,125
R03 · FY2002 · EY